INCIDENCE OF MALIGNANT NEOPLASMS, MORTALITY CAUSED BY THEM AND THE STATE OF ONCOLOGICAL CARE IN THE CONTEXT OF THE COVID-19 PANDEMIC
DOI:
https://doi.org/10.11603/1681-2786.2023.4.14419Keywords:
COVID-19 pandemia, malignant neoplasms, morbidity, mortality, anticancer treatmentAbstract
Purpose: to analyze the dynamics of morbidity and mortality from malignant neoplasms (MN) in Transcarpathia region (2019–2021), to compare the available data with mortality rates from COVID-19. To evaluate the dynamics and informativeness of the integral indicator of the quality of oncology care – the mortality/morbidity ratio at 2020–2021. To evaluate the impact of quarantine restrictions on the availability of specialized oncology care and coverage of oncology patients with special treatment.
Materials and Methods. Data of the state statistical reporting based on the materials of the National Cancer Registry of Ukraine, local reports of the oncology service in the Transcarpathian region and the city of Uzhgorod regarding the dynamics of morbidity, mortality and coverage of special treatment of cancer patients at 2019–2021, similar indicators of population involvement by the COVID-19 pandemia in 2020–2021 were analised.
Results. In the conditions of the COVID-19 pandemia, remained the focus all efforts of the medical service on resolving of urgent anti-epidemic tasks. In 2021, the COVID-19 mortality rate in the city of Uzhgorod equaled and exceeded that from MN (250.0 vs. 173.7 per 100.000 population). In 2020–2021, the intensive mortality rates from MN stabilized – 182.6 and 173.7 per 100.000 urban population (in Zakarpattia region – increased from 102.6 to 131.9 per 100.000 population, respectively. In quarantine restrictions in Zakarpattia, it was possible maintain a sufficient level of consultative and specialized care for patients with malignant neoplasms.
Conclusions. The incidence rate of cancer in the region in 2020 compared to this data before the start of the COVID-19 pandemia in 2019 showed a decrease, which is probably related to the “underreportingˮ of new cases due to a decrease in the number of visits to the hospital under quarantine restrictions. Coverage of primary cancer patients in Transkarpatian region with specialised treatment in 2020–2021 was from 66 to 73 %, which reflects the impact of quarantine restrictions on the availability of specialized oncological care. Despite the limitations due to the SARS-CoV-2 (COVID-19) pandemia, the majority of patients with newly diagnosed MN received an adequate anticancer treatment.
References
(2021). Rak v Ukrayini, 2019–2020. Zakhvoryuvanist, smertnist, pokaznyky diyalnosti onkolohichnoyi sluzhby [Cancer in Ukraine, 2019–2020. Morbidity, mortality, performance indicators of the oncology service]. Byuleten Natsionalnoho kantser-reyestru Ukrayiny – Bulletin of the National Cancer Registry of Ukraine. (No. 22). Kyiv. Retrieved from: http://www.ncru.inf.ua/publications/BULL_22/ [in Ukrainian].
(2022). Rak v Ukrayini, 2020–2021. Zakhvoryuvanist, smertnist, pokaznyky diyalnosti onkolohichnoyi sluzhby [Cancer in Ukraine, 2020–2021. Morbidity, mortality, performance indicators of the oncology service]. Byuleten Natsionalnoho kantser-reyestru Ukrayiny – Bulletin of the National Cancer Registry of Ukraine. (No. 23). Kyiv. Retrieved from: http://www.ncru.inf.ua/publications/BULL_23/index.htm [in Ukrainian].
(2023). Rak v Ukrayini, 2021–2022. Zakhvoryuvanist, smertnist, pokaznyky diyalnosti onkolohichnoyi sluzhby [Cancer in Ukraine, 2021–2022. Morbidity, mortality, performance indicators of the oncology service]. Byuleten Natsionalnoho kantser-reyestru Ukrayiny – Bulletin of the National Cancer Registry of Ukraine. (No. 24). Kyiv. Retrieved from: http://www.ncru.inf.ua/publications/BULL_24/index.htm [in Ukrainian].
Pelle, F., Cappelli, S., Graziano, F., Piarulli, L., Cavicchi, F., Magagnano, D., … Botti, C. (2020). Breast cancer surgery during the COVID-19 pandemic: a monocentre experience from the Regina Elena National Cancer Institute of Rome. J. Exp. Clin. Cancer Res., 39(1), 171. DOI 10.1186/s13046-020-01683-y. DOI: https://doi.org/10.1186/s13046-020-01683-y
Boyd, C.J., Hemal, K., Ramesh, S., Bekisz, J.M., Salibian, A.A., Thanik, V., … Karp, N.S. (2022). Breast reconstruction during the COVID-19 pandemic: Single institution experience from the pandemic’s epicenter in the United States. J. Plast. Reconstr. Aesthet. Surg., 75(7), 2236-2241. DOI 10.1016/j.bjps.2022.02.021. DOI: https://doi.org/10.1016/j.bjps.2022.02.021
Dienemann, T., Brennfleck, F., Dejaco, A., Grützman, R., Binder, J., Krautz, C., … Brunner, S.M. (2021). Collateral effects of the SARS-CoV-2 pandemic on oncologic surgery in Bavaria. BMC Surg., 21(1), 411. DOI 10.1186/s12893-021-01404-y. DOI: https://doi.org/10.1186/s12893-021-01404-y
Ades, F., Senterre, C., de Azambuja, E., Sullivan, R., Popescu, R.A., Parent, F., & Piccart, M. (2013). Discrepancies in cancer incidence and mortality and its relationship to health expenditure in the 27 European Union member states. Ann. Oncol., 24(11), 2897-2902. DOI 10.1093/annonc/mdt352. DOI: https://doi.org/10.1093/annonc/mdt352
Colombo, I., Zaccarelli, E., Del Grande, M., Tomao, F., Multinu, F., Betella, I., … Colombo, N. (2020). ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies. ESMO Open, 5(3). DOI 10.1136/esmoopen-2020-000827. DOI: https://doi.org/10.1136/esmoopen-2020-000827
Lowe-Zinola, J., Williamson, M., Gaunt, E., Lowe-Zinola, J., Williamson, M., Gaunt, E., … Yap, J. (2022). Evaluating the impact of the COVID-19 pandemic on tertiary gynaecological cancer care delivery: a population based study. J. Obstet. Gynaecol., 42(8), 3692-3700. DOI 10.1080/01443615.2022.2153296. DOI: https://doi.org/10.1080/01443615.2022.2153296
Amparore, D., Campi, R., Checcucci, E., Sessa, F., Pecoraro, A., Minervini, A., … Porpiglia, F. (2020). Forecasting the Future of Urology Practice: A Comprehensive Review of the Recommendations by International and European Associations on Priority Procedures During the COVID-19 Pandemic. Eur. Urol. Focus, 6(5), 1032-1048. DOI 10.1016/j.euf.2020.05.007. DOI: https://doi.org/10.1016/j.euf.2020.05.007
Nogami, Y., Kobayashi, Y., Tsuji, K., Yokota, M., Nishio, H., Nakamura, M., … Aoki, D. (2020). Impact of the COVID-19 epidemic at a high-volume facility in gynecological oncology in Tokyo, Japan: a single-center experience. J. Ovarian Res., 13(1), 105. DOI 10.1186/s13048-020-00711-x. DOI: https://doi.org/10.1186/s13048-020-00711-x
Antunes, D., Mendonça, L., Melo, Â., Gonçalves, S., Martins, F.N., & Martins, N.N. (2022). Impact of the COVID-19 Pandemic on Diagnosis and Management of Gynecological Cancer: A Single-Center Analysis. Medicina (Kaunas), 58(12). DOI 10.3390/medicina58121862. DOI: https://doi.org/10.3390/medicina58121862
Krajewska (Wojciechowska), J., Krajewski, W., Zub, K., & Zatoński, T. (2020). Review of practical recommendations for otolaryngologists and head and neck surgeons during the COVID-19 pandemic. Auris Nasus Larynx, 47(4), 544-558. DOI 10.1016/j.anl.2020.05.022. DOI: https://doi.org/10.1016/j.anl.2020.05.022
Purdy, A.C., Smith, B.R., Hohmann, S.F., & Nguyen, N.T. (2022). The impact of the novel coronavirus pandemic on gastrointestinal operative volume in the United States. Surg. Endosc., 36(3), 1943-1949. DOI 10.1007/s00464-021-08477 z. DOI: https://doi.org/10.1007/s00464-021-08477-z
(2023). WHO. Retrieved from: www.who.int/news/item/05-05-2023-statement-on-the-fifteenthmeeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic.
(2023). WHO. From emergency response to long-term COVID-19 disease management: sustaining gains made during the COVID-19 pandemic. Retrieved from: www.who.int/publications/i/item/WHO-WHE-SPP-2023.1.
Wise, J. (2023). COVID-19: WHO declares end of global health emergency. BMJ, 381, 1041. DOI 10.1136/bmj.p1041. DOI: https://doi.org/10.1136/bmj.p1041
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Bulletin of Social Hygiene and Health Protection Organization of Ukraine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
